Results 141 to 150 of about 1,055,367 (200)

Summary of Research: Risdiplam Treatment Following Onasemnogene Abeparvovec in Individuals with Spinal Muscular Atrophy: A Multicenter Case Series. [PDF]

Adv Ther
Svoboda MD, Kuntz N, Leon-Astudillo C, Byrne BJ, Krueger J, Kwon JM, Sieburg C, Castro D.   +7 more
europepmc   +1 more source

Effect size estimation in cooperative group- and industry-sponsored phase 3 oncology trials. [PDF]

J Natl Cancer Inst
Noticewala SS, Grippin AJ, Kouzy R, Abi Jaoude J, Miller A, Sherry A, Ludmir EB.   +6 more
europepmc   +1 more source

Developing immersive virtual exposures for obsessive-compulsive disorder – Protocol for a Randomised, Controlled, Proof-of-Concept Feasibility Trial

Costa MPd, Abreu A, Fialho C, Lange M, Carter B, Grácio J, Loktyushin A, Molaei F, Stelzer J, Krakauer J, Oliveira-Maia AJ.   +10 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Access to data in industry-sponsored trials

The Lancet, 2011
Lundh, Andreas, Krogsbøll, Lasse T, Gøtzsche, Peter C   +2 more
openaire   +5 more sources

Sponsored Data: Smarter Data Pricing with Incomplete Information

Information Systems Research, 2022
With the development of data-intensive internet services, the world has witnessed explosive growth in mobile data consumption during the last couple of years. The upcoming generation of 5G-capable phones and networks will continue and even accelerate that process.
Xiaowei Mei, Hsing Kenneth Cheng, Subhajyoti Bandyopadhyay, Liangfei Qiu, Lai Wei   +4 more
openaire   +2 more sources